Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes

This trial is conducted in Europe. The aim of this observational study is to evaluate the glycaemic control in patients with type 1 or 2 diabetes using NovoMix® 30 or Levemir® under normal clinical practice conditions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Autoimmune Diseases Diabetes Mellitus Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Novo Nordisk Investigational Site

Skopje, MK-1000, North Macedonia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Levemir® above 6 yrs
NovoMix® 30 above 18 yrs
Patients with Type 1 or Type 2 diabetes, including newly diagnosed

Exclusion criteria

Current treatment with NovoMix® 30 or Levemir®

Treatment and study plan

biphasic insulin aspart 30

Drug

Start dose and frequency prescribed by the physician as a result of a normal clinical evaluation

Other names: NovoMix® 30, BIASP

insulin detemir

Drug

Start dose and frequency prescribed by the physician as a result of a normal clinical evaluation

Primary outcomes

HbA1c

Time frame: at 24 weeks

Secondary outcomes

FPG, PG profile, weight, % of subjects on target

Time frame: at 24 weeks

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Official study title

A Prospective, Multicentre, Open Label, Non-controlled, Observational, 24-week Study in Patients Using NovoMix® 30 (Biphasic Insulin Aspart 30) or Levemir® (Insulin Detemir) for Treatment of Type 1 or Type 2 Diabetes Mellitus in Macedonia

Important dates

Study start: 2007
Primary completion: 2008
Study completion: 2008
First posted: Apr 23, 2008
Registry last updated: Jan 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed